Bio-Rad launches real-time PCR system

Create PDF

March 2023—Bio-Rad launched its CFX Opus Deepwell Dx real-time PCR system, an open platform for developing in vitro diagnostic assays. The system multiplexes up to five targets and allows reaction volumes up to 125 µL in a 96-well format for quantitative PCR diagnostic assays. CFX Maestro Dx SE software provides data management and analysis tools.

The system is listed with the FDA for in vitro diagnostic testing and developed in accordance with the European Union’s regulations for IVD medical devices. The company says it will continue to seek regulatory approvals for additional markets worldwide.